CSA Medical

CSA Medical, Inc, has appointed Jean Bjerke, MBA as Vice President of Marketing. In this role, Ms. Bjerke will have the responsibility of developing and implementing the strategic marketing approach for the company's product lines.

CSA Medical announced on Thursday, the expansion of its truFreeze® label to refer specifically to Barrett's Esophagus with high grade dysplasia.

CSA Medical today announced new clinical data related to its truFreeze® Spray Cryotherapy (SCT) system to be presented in a series of oral and poster presentations at Digestive Disease Week® (DDW) 2017 in Chicago, Illinois.

The initial two studies of the revolutionary treatment for Chronic Bronchitis are highlighted in the Research Letter

CSA Medical today announced the initial use of a modified cryogen decompression tube (CDT) during a truFreeze Spray Cryotherapy (SCT) case at Dartmouth-Hitchcock Medical Center.  Dr.

Chronic Bronchitis clinical study milestone achieved on World COPD Day

The data included 60 day follow-up results on eleven patients treated with the RejuvenAir System.

The mini-symposium will take place on Tuesday Evening, September 6, 2016 in London, England

Thermal Penetration results from liquid nitrogen, nitrous oxide and carbon dioxide will be presented at DDW in May 2016

Results from the truFreeze® spray cryotherapy registry and independent clinical studies will be presented at WCBIP and ATS in May 2016